Part 7/9:
Christine emphasized that not all sectors are winner-takes-all, allowing for multiple investment opportunities within the same healthcare subfield. This approach has proven successful, as illustrated by their discussions on CAR-T therapy companies like Kite Pharma and Juno Therapeutics, where both ended up being profitable despite initial disagreements on which stock was the better pick.